An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity - Archive ouverte HAL Access content directly
Journal Articles Life Science Alliance Year : 2023

An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity

Richard Miallot
  • Function : Author
  • PersonId : 1246613
Virginie Millet
  • Function : Author
Yann Groult
  • Function : Author
Angelika Modelska
  • Function : Author
Lydie Crescence
  • Function : Author
Sandrine Roulland
  • Function : Author
Sandrine Henri
Bernard Malissen
  • Function : Author
Nicolas Brouilly
  • Function : Author
Laurence Panicot-Dubois
Pascal Finetti
  • Function : Author
François Bertucci
  • Function : Author
Franck Galland
  • Function : Author
Philippe Naquet

Abstract

Aggressive tumors often display mitochondrial dysfunction. Upon oxidative stress, mitochondria undergo fission through OMA1mediated cleavage of the fusion effector OPA1. In yeast, a redoxsensing switch participates in OMA1 activation. 3D modeling of OMA1 comforted the notion that cysteine 403 might participate in a similar sensor in mammalian cells. Using prime editing, we developed a mouse sarcoma cell line in which OMA1 cysteine 403 was mutated in alanine. Mutant cells showed impaired mitochondrial responses to stress including ATP production, reduced fission, resistance to apoptosis, and enhanced mitochondrial DNA release. This mutation prevented tumor development in immunocompetent, but not nude or cDC1 dendritic cell-deficient, mice. These cells prime CD8 + lymphocytes that accumulate in mutant tumors, whereas their depletion delays tumor control. Thus, OMA1 inactivation increased the development of anti-tumor immunity. Patients with complex genomic soft tissue sarcoma showed variations in the level of OMA1 and OPA1 transcripts. High expression of OPA1 in primary tumors was associated with shorter metastasisfree survival after surgery, and low expression of OPA1, with anti-tumor immune signatures. Targeting OMA1 activity may enhance sarcoma immunogenicity.

Dates and versions

hal-04066238 , version 1 (12-04-2023)

Identifiers

Cite

Richard Miallot, Virginie Millet, Yann Groult, Angelika Modelska, Lydie Crescence, et al.. An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity. Life Science Alliance, 2023, 6, ⟨10.26508/lsa.202201767⟩. ⟨hal-04066238⟩
19 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More